Hot Takes
One-line opinions on every company we track. Spicy. Subjective. Sometimes correct.
"The category they sit in is theirs now. Period."
"The throne stays warm. 47 weeks at #1 and counting."
"Pure momentum stock. Caveat emptor on the science."
"The oil wars are over. doTERRA won."
"The MLM Wall Street takes seriously."
"Recession-proof MLM. And the knives are actually good."
"The MLM nobody calls an MLM. Smart."
"Built a moat by not looking like an MLM."
"Underrated by industry, overrated by mom-tubers. Perfect."
"Number two with a long memory."
"Old school, but cash-machine consistent."
"Boring + regulated = enduring."
"Legal win was bigger than the products. For now."
"Boring is a strategy. It's working."
"The comeback narrative needs receipts soon."
"Right category, right time."
"Niche dominance has a ceiling. They're near it."
"Hardware bets are getting interesting. Watch closely."
"Cleaning category sleeper."
"Wellness reset crowd is theirs to lose."
"Polarizing as ever. The cult is still buying."
"Patient brand in an impatient category."
"The most successful brand you forgot exists."
"Cultural tailwind that nobody is talking about."
"TikTok loves a drop. So do they."
"Repositioned harder than most. It's paying."
"Fighting pharmaceuticals with shakes. Hard mode."
"One legendary product. Forever defining them."
"The grandparent in the room."
"Anti-Ozempic crowd is a real market now."
"Underrated by industry watchers. Not by their reps."
"The pink drink isn't trending. Reps still are."
"Buffett's quietest grower."
"International story is the only story."
"Need a Lash Boost-sized hit. Fast."
"Smaller, but uniquely positioned right now."
"Picks-and-shovels for the energy MLM space."
"Two stories. One is winning."
"Functional coffee is crowded. They were early though."
"One regulatory cycle from over."
"Periodic viral waves. Then the trough."
"Cautionary tale wearing 3D fiber lashes."
"Regulators are watching this whole category."
"Believers believe. Everyone else asks questions."
"The $5 dream ran into the IRS."
"Antioxidant category cratered. They're stuck."
"Saga continues. So do the lawsuits."
"Time capsule company. Not bad. Not growing."